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Cromolyn Sodium (CS) is an effective therapeutic agent in the xophylaxis of bronchial asthma. Although its specific mechanisn ) f action has not been elucidated, CS has been shown to inhibit nediator release in the imediate hypersensitivity reaction.
The effects of CS upon the chemotactic response of human inllanunatory cells have not been extensively investigated. We have emonstrated that CS is not chemotactic for either human neutro-,hi19 (HN) or eosinophils. Incubation of HN with CS for 30' :370C) prior to chemotaxis did not affect the response of HN tooard standard chemotactic factors: zymosan activated serum (ZAS), :5a or normal human serum (NHS) which was allowed to clot at 3 7 ' 1 for 1 hr. and then heat inactivated at 56O for 30'. Further :hernotactic studies were performed utilizing untreated HN and in-:remental concentrations of CS added to each of the above standard chemotactants. Incremental conc. of CS to 1 0 -~~) tdded to ZAS or C5a did not affect the chemotactic response of HI ,rhile after identical molar conc. of CS were added to HNS the emotactic stimulus was diminished. The role of the neutrophil in immediate hypersensitivity has come prominent with the identification of a neutrophil chemoctic factor (NCF). The data suggest that CS may inhibit serum rived chemotactic activity, perhaps complement-independent ctpr with resultant modification of the imediate hyper9s t -T LYMPHOCYTES. Frank C. Schmalstiea. Helen B. udloff, Donald R. Barnett, and Amond S. Goldman.
and Human Biological Chemistry and Genetics, ]The University of Texas Medical Branch, Galveston, Texas
We have shown that a high molecular weight factor present in plasma and serum reduced the number of human T lymphocytes exhibiting the motile configuration. In contrast, B lymphocyte morphology was not affected. The activity of this factor was abolished by pepsin or trypsin, and significantly diminished by phospholipase C. Neuraminidase, phospholipase A, phospholipase D or heparin induced serum lipase activity did not change the activity of the inhibitor. Antisera to human 0-lipoprotein was capable of removing most of the inhibitory activity from normal human serum. Gel filtration of serum with sephadex G-200 and Bio-Gel A-5M suggested that the molecular weight of this factor was approximately 1-2 x lo6 daltons. The inhibitory material was isolated from serum by the following procedures: 1)precipitation by heparin and magnesium chloride; 2)sequc-tial flotation by ultracentrifugation; and 3)affinity chroma.ography on concanavalin A-sepharose 48 columns. The inhibitor appears to be a lip0 protein residing in the LDL2 lipoprotein fraction (density 1.030 1.073 g/dl) that is not retained on concanavalin A-sephamse 4B columns. Our studies indicated that the lipoprotein which regulates T cell morphology is distinct from those which inhibit PHA stimulation of human lymphocytes and E-rosette formation. T-LYMPHOCYTES BEFORE ALL RELAPSE AND in STUDIES. Michael R. Shar e* Herschel P. Bentle. nd D.fi. Peterson, Degariment or Pealatrlcs, or soutn AlaDama, Mobile, Alabama T-lymphocytes were noted to decline for 2 acute lymphocytic leukemia (AIL) patients prior to relapse and incubation of these lymphocytes with thymosin(200ug/ml) and/or plasma increased the proportion of E-rosettes. To evaluate this induction of sheep erythrocyte(SRBC) receptors, we have studied the influence of thymosin and/or plasma on regeneration of SRBC receptorsby trypsinized normal and leukemic lymphocytes.
Decreases in E-rosette forming lymphocytes were observedinm~ ALL patients preceeding relapse with values of 50% E-rosettes to 24% over three weeks and 58% to 9% over eight weeks. Incubation >f lymphocytes from the second patient in fresh AB negative plasma for 18 hours at 3 7 O~ increased E-rosettes from 14% to 32% After peripheral blood lymphoblasts appeared, incubation with thymosin gave values of 18% pre-and 41% post-incubation. Plasma incubation of lymphocytes from a Hodgkin's disease patient increased E-rosettes from 2% to 32%.
Eight normal subjects had E-rosettes of 60% + 2.2 before and 6% 5 2.7 after trypsin treatment. Incubation of these jpphocyter in plasma with thymosin(61% 5 0.9) or plasma alone (68% 2 3.0) allowed complete regeneration. Thyuwsin alone and HBSS gave values of 46% 5 3.4 and 48% 5 4.9. Six ALL patients in remission had values of 60% 5 4.9 before and 9% 3.3 after trypsin treatment with regeneration >53% in all media. It is concluded that lymphocytes from W patients in remission after trypsinization, regenerate receptors for SRBC without thymosin or plasma factors CHEMILUMINESCENCE RESPONSE OF NE N Ann 0. Shigeoka, Craig D. Allred: ::byL:= versitv of Utah Colleqe of Medicine, Dept. of Pedi--atrics and pathology, Salt Lake ~;ty, Utah.
Neonatal PMN may have abnormal metabolic function leading to defects in intracellular microbicidal activity. We have studied leukocytes from 14 healthy term infants and 5 stressed premature (30-36 weeks gestation) infants in order to determine the presence of functional abnormalities associated with ingestion of op sonized zymosan or group B streptococci. PMN separated by dextran sedimentation with ammonium chloride induced erythrocyte lysis were washed twice and resuspended in PBS. Control cells were obtained from normal adult volunteers. Stud'es were performed using both a chemiluminescence (CL) and a I H labeleA grou B streptococcal uptake technique. Chemiluminescence from term neonatal PMN was comparable to adult controls in all instances when zymosan was used as the ingested particle. Two of the term infants tested, however, showed depressed CL in response to opsonized group B streptococci. In contrast, CL studies of the stressed neonatal PMN were abnormal in 3 of 5 instances using opsonized zymosan and all 5 instances with group B streptococci.
No phagocytic defect was evident by radiolabeled group B strepta coccal uptake and microscopic examination. Since chemiluminescence is produced when the microbicidal mechanism of the neutrophi1 is activated, the abnormal results suggest a metabolic abnormality is present in some term and most preterm neonatal PMN.
The presence of this defect may contribute to the high mortalit) observed with infection in stressed, preterm infants.
